BCM
TEVA icon

BBT Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

BBT Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100,000
Closed -$5.28M – 271
2014
Q1 		$5.28M Hold
100,000
– – 0.24% 106
2013
Q4 		$4.01M Buy
+100,000
New +$3.94M 0.18% 136

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BBT Capital Management's TEVA Position: Q4 2015 in Review

BBT Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 4,143 shares — an estimated $234K sold.

BBT Capital Management first reported a position in TEVA in Q4 2013 and held it in 5 quarters. The position peaked at $2.75M in Q4 2013. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • BBT Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • BBT Capital Management sold 4,143 Teva Pharmaceuticals shares in Q4 2015, an estimated $234K.
  • BBT Capital Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • BBT Capital Management's Teva Pharmaceuticals position peaked at $2.75M in Q4 2013.
  • 876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on BBT Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.